BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 27617275)

  • 1. Genetic Factors in Intervertebral Disc Degeneration.
    Feng Y; Egan B; Wang J
    Genes Dis; 2016 Sep; 3(3):178-185. PubMed ID: 27617275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc.
    Feng C; Liu H; Yang Y; Huang B; Zhou Y
    Cell Physiol Biochem; 2015; 35(1):1-16. PubMed ID: 25547527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut-disc axis: A cause of intervertebral disc degeneration and low back pain?
    Li W; Lai K; Chopra N; Zheng Z; Das A; Diwan AD
    Eur Spine J; 2022 Apr; 31(4):917-925. PubMed ID: 35286474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in intervertebral disc degeneration: Molecular mechanisms, pathogenesis and treatment.
    Wang Y; Cheng H; Wang T; Zhang K; Zhang Y; Kang X
    Cell Prolif; 2023 Sep; 56(9):e13448. PubMed ID: 36915968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the mechanisms of intervertebral disc degeneration: an exploration of the p38 MAPK signaling pathway.
    Zhang X; Zhang Z; Zou X; Wang Y; Qi J; Han S; Xin J; Zheng Z; Wei L; Zhang T; Zhang S
    Front Cell Dev Biol; 2023; 11():1324561. PubMed ID: 38313000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Managing Spinal Intervertebral Discs Degeneration.
    Costăchescu B; Niculescu AG; Teleanu RI; Iliescu BF; Rădulescu M; Grumezescu AM; Dabija MG
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role and therapeutic implications of p53 in intervertebral disc degeneration.
    Wang Y; Hu S; Zhang W; Zhang B; Yang Z
    Cell Death Discov; 2023 Dec; 9(1):433. PubMed ID: 38040675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanisms and Functions of GDF-5 in Intervertebral Disc Degeneration.
    Guo S; Cui L; Xiao C; Wang C; Zhu B; Liu X; Li Y; Liu X; Wang D; Li S
    Orthop Surg; 2021 May; 13(3):734-741. PubMed ID: 33817978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals.
    Kang L; Zhang H; Jia C; Zhang R; Shen C
    Front Pharmacol; 2022; 13():956355. PubMed ID: 35903342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products can modulate inflammation in intervertebral disc degeneration.
    Liu Z; Zhu J; Liu H; Fu C
    Front Pharmacol; 2023; 14():1150835. PubMed ID: 36874009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervertebral Disc Biology: Genetic Basis of Disc Degeneration.
    Munir S; Rade M; Määttä JH; Freidin MB; Williams FMK
    Curr Mol Biol Rep; 2018; 4(4):143-150. PubMed ID: 30464887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathomechanism of intervertebral disc degeneration.
    Oichi T; Taniguchi Y; Oshima Y; Tanaka S; Saito T
    JOR Spine; 2020 Mar; 3(1):e1076. PubMed ID: 32211588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration.
    Wang C; Yu X; Yan Y; Yang W; Zhang S; Xiang Y; Zhang J; Wang W
    Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):1-13. PubMed ID: 27864283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset of disc degeneration in SM/J mice is associated with changes in ion transport systems and fibrotic events.
    Zhang Y; Xiong C; Kudelko M; Li Y; Wang C; Wong YL; Tam V; Rai MF; Cheverud J; Lawson HA; Sandell L; Chan WCW; Cheah KSE; Sham PC; Chan D
    Matrix Biol; 2018 Sep; 70():123-139. PubMed ID: 29649547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of single and cooperative different delivery systems for the treatment of intervertebral disc degeneration.
    Liu Z; Fu C
    Front Bioeng Biotechnol; 2022; 10():1058251. PubMed ID: 36452213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From drugs to biomaterials: a review of emerging therapeutic strategies for intervertebral disc inflammation.
    Yang S; Jing S; Wang S; Jia F
    Front Cell Infect Microbiol; 2024; 14():1303645. PubMed ID: 38352058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration.
    Wei B; Zhao Y; Li W; Zhang S; Yan M; Hu Z; Gao B
    Front Bioeng Biotechnol; 2022; 10():1023877. PubMed ID: 36299288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructing intervertebral disc degeneration animal model: A review of current models.
    Liang T; Gao B; Zhou J; Qiu X; Qiu J; Chen T; Liang Y; Gao W; Qiu X; Lin Y
    Front Surg; 2022; 9():1089244. PubMed ID: 36969323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction.
    Sobajima S; Shimer AL; Chadderdon RC; Kompel JF; Kim JS; Gilbertson LG; Kang JD
    Spine J; 2005; 5(1):14-23. PubMed ID: 15653081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mediators and signalling pathways controlling intervertebral disc degeneration.
    Navone SE; Marfia G; Giannoni A; Beretta M; Guarnaccia L; Gualtierotti R; Nicoli D; Rampini P; Campanella R
    Histol Histopathol; 2017 Jun; 32(6):523-542. PubMed ID: 27848245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.